PMLiVE | Pharmaceutical industry news, articles, jobs, reports, …
Dec 23, 2021 · Iona Everson from PMGroup spoke to John Forni, Country Medical Director at Sanofi UK & Ireland, about the escalating challenges of treating chronic obstructive pulmonary disease (COPD) in the UK and how the government, NHS and industry can work together to …
PMLiVE | Pharmaceutical industry news, articles, jobs, reports, …
December 6, 2024 | Genesis Research Group| To better understand how MFPs might impact payer utilization management strategies, rebate negotiations, and business approaches, Genesis Research Group employed their RPR stakeholder engagement platform …
PMLiVE | Pharmaceutical industry news, articles, jobs, reports, …
Susanne Bobadilla from VML Health, joined by a team of 15 medical, digital strategists and client engagement experts from across the company, looks at the top trends coming out of ESMO 2024 and what they mean for the future of cancer care
PME - Articles - Pharmaceutical Market Europe
Dec 15, 2024 · Discover the latest articles published by PME. Pharmaceutical industry news, articles, jobs, reports, advice and services!
PME - Home
How AI and digital innovations can help agencies and pharma support HCPs in the fight against COVID-19 - PME Supplement August 2020. As the realities of COVID-19 hit and lockdown restrictions came into force around the world, agencies and pharma suddenly found themselves embracing AI and digital innovations at an accelerated rate.
Eli Lilly’s Omvoh granted FDA approval to treat Crohn’s disease in ...
3 days ago · Eli Lilly’s Omvoh (mirikizumab-mrkz) has been approved by the US Food and Drug Administration (FDA) to treat adults with moderately to severely active Crohn’s disease. Crohn’s disease is one of the two main types of inflammatory bowel disease (IBD), which affects almost one in every 100 people ...
AstraZeneca’s Calquence granted FDA approval in untreated …
2 days ago · AstraZeneca’s (AZ) Calquence (acalabrutinib) has been approved by the US Food and Drug Administration (FDA) as part of a combination treatment for mantle cell lymphoma (MCL). The drug has been authorised for use alongside standard-of-care chemoimmunotherapy, bendamustine and rituximab, in ...
Appointments - pme.pmlive.com
Edelman has appointed Anthony Chelvanathan as global creative partner. Chelvanathan, who will retain his chief creative officer role for Edelman Canada, has extensive industry experience. Prior to joining the firm, he worked his way up through a number of creative directing roles at Leo Burnett Toronto, culminating in his appointment as senior vice president.
Regeneron shares positive phase 3 results for Libtayo in high-risk …
4 days ago · Regeneron Pharmaceuticals has shared positive results from a late-stage trial of Libtayo (cemiplimab) in patients with high-risk cutaneous squamous cell carcinoma (CSCC) after surgery. The phase 3 C-POST trial has been comparing adjuvant treatment with the PD-1 inhibitor against placebo in patients ...
About us - PMLiVE
DESIGN AND PRODUCTION. Hina Mistry – Designer Email: [email protected] Tel: +44 (0)1372 414 272. Anamaria Popescu – Front-End Developer Email: [email protected] Tel: +44 (0)1372 414 262